Recombinant Mouse Klra3 Protein，His

Klra3, also known as KLRD1 or CD94, is a key member of the C-type lectin-like receptor family and plays a significant role in the immune response, particularly in the recognition of stressed or infected cells by natural killer (NK) cells and some T cells. The study of Klra3 recombinant protein is crucial for understanding its structural and functional properties, which are pivotal in immune regulation and response. Researchers have focused on the characterization of Klra3 due to its involvement in various diseases, including cancer and autoimmune disorders, where its expression can be altered. The recombinant protein allows for detailed studies of its interaction with other molecules, such as HLA-E and other ligands, which are essential for NK cell activation and signaling. Furthermore, Klra3's potential as a therapeutic target is under investigation, as modulating its activity could enhance anti-tumor immunity or correct aberrant immune responses. Establishing effective recombinant production systems for Klra3 not only facilitates the exploration of its biological functions but also advances the development of immunotherapeutic strategies. Understanding the dynamics of Klra3 interactions and its signaling pathways can reveal insights into its role in health and disease, ultimately contributing to the development of innovative treatments aimed at harnessing or reprogramming the immune system. Research in this area remains critical, as elucidating Klra3's mechanisms may lead to breakthroughs in immunotherapy and a better understanding of immune evasion by tumors.